BioCryst’s RAPIVAB(TM) (peramivir injection) received FDA approval for treatment of influenza in adults
On Dec. 22, 2014, BioCryst Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) had approved RAPIVAB (peramivir…
On Dec. 22, 2014, BioCryst Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) had approved RAPIVAB (peramivir…
On Dec. 3, 2014, Fred Eshelman, CEO and founder of Wilmington-based PPD Inc. and a member of the…
On Oct. 3, 2014, Canadian diamond pioneer Charles Fipke donated $9.1 million for Alzheimer’s research at the University…
On Sept. 19, 2014, the Centers for Disease Control and Prevention”s (CDC) Advisory Committee on Immunization Practices (ACIP)…
On Mar. 6, 2014, Merck announced that it had sold Sirna to Alnylam for $175 million. Sirna, orginally…
On Jan 14, 2014, Illumina announced that it had broken the ‘sound barrier’ of human genomics by enabling…
On Nov. 7, 2013 – Syntrix Biosystems announced a federal court in Tacoma, had granted the Auburn-based company…
On Oct. 2, 2013, Capsugel, the New Jersey medication capsule maker, announced it has completed its acquisition of…
On Jul. 23, 2013, Matrical Bioscience announced that it had signed a definitive agreement to acquire the assets…
In Jun. 7, 2013, the University of Nebraska Board of Regents approved changing the name of the UNMC…
On April 9, 2013, the American Chemical Society (ACS) awarded the Priestley Medal to Peter J. Stang “for…
On Jan. 4, 2013, Sanford Health announced the acquisition of Sioux Falls-based biotech company Hematech, a subsidiary of…
On Nov. 15, 2012, the U.S. Centers for Disease Control and Prevention (CDC) responded to the fungal meningitis…
On Nov. 8, 2012, Atossa Genetics, the Breast Health Company completed its IPO with gross proceeds of $4…
On Oct. 4, 2012, Takeda Pharmaceutical and LigoCyte Pharmaceuticals jointly announced that Takeda’s wholly-owned subsidiary, Takeda America Holdings…
On Aug. 3, 2012, GlaxoSmithKline announced that it had completed its acquisition of Human Genome Sciences for US$3.6…
On Jun. 26, 2012, Roche announced it had closed the Nutley plant, established in 1929. The Nutley plant…
On Apr. 25, 2012, U.S. Representatives Jim Cooper (D-Tenn.), Charlie Dent (R-Pa.), and Robert J. Dold (R-Ill.) joined…
On Aug. 30, 2011, Amnis, a Seattle-based manufacturer of advanced cell imaging systems, announced the company had been…
On Aug. 17, 2011, researchers at the Stanford University School of Medicine announced they had paired up medicines…
On Feb. 22, 2011, Foster City, California-based Gilead Sciences and Calistoga Pharmaceuticals announced Gilead’s acquisition of Calistoga for…
On Feb. 16, 2016, Sanofi-aventis announced it would acquired Genzyme for $74 a share in cash or $21.1…
On Oct. 28, 2010, Emergent BioSolutions announced it had completed the acquisition of Seatte-based Trubion Pharmaceutical for upfront…
On Jul. 22, 2010, MDRNA announced that MDRNA shareholders approved the issuance of shares of MDRNA common stock…
On Mar. 26, 2009, Roche completed its acquisition of Genentech for $46.8 billion pursuant to a short-form merger…
On Nov. 19, 2008, The Science & Entertainment Exchange was officially announced and launched by the National Academy…
On Aug. 20, 2008, Sonus Pharmaceuticals was acquired by OncoGenex Technologies in a reverse merger transaction worth $10.36…
On Jul. 22, 2008, Bentley Pharmaceuticals was acquired by Teva Pharmaceutical Industries. At closing, Bentley consisted solely of…
On Jun. 1, 2008, Oregon BioEvolution was published illustrating life science companies and non-profit research organization in the…
On May 21, 2008, the North Carolina School of Pharmacy was renamed the Eshelman School of Pharmacy in…